Davenport & Co LLC
- SEC CIK
- 0000887777
- Latest filing
- Jul 13, 2026
PLX holding history
Protalix BioTherapeutics, Inc. in every 13F filed by Davenport & Co LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PLX overviewAll 13F holders of PLXFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −22,000−100.0% | Sold out | Holders |
| Q3 2022 | 22,000 | $23.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 22,000 | $24.0K | <0.1% | +10,000+83.3% | Added | Holders |
| Q1 2022 | 12,000 | $13.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 12,000 | $10.0K | <0.1% | −24,000−66.7% | Reduced | Holders |
| Q3 2021 | 36,000 | $48.0K | <0.1% | +24,000+200.0% | Added | Holders |
| Q2 2021 | 12,000 | $23.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 12,000 | $54.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.